Fibromyalgia Is Not In Your Head: Root Causes and What the Research Points To
2026-10-31Same post, two depths. Switch any time; the research version has the enzyme names, lab markers, and doses. Written from a research and education perspective: a model of what may be going on and what the published literature suggests would address it if the model is right, not medical advice or a treatment plan.
Print the one-page card (PDF): the levers, up front, on a single sheet.
Wallet-size medical information card to fill in with your clinician: ME/CFS and post-exertional malaise (10-up sheet) · POTS (10-up sheet).
Lets talk about fibromyalgia, because I think it is one of the most badly explained diagnoses in medicine. You get told your pain is real but there is nothing wrong with you, that your tests are normal, and that the plan is an antidepressant, a nerve pain drug, and "try to exercise." I have watched a lot of people I have worked with do exactly that for years and stay exactly where they were.
Here is what I think is really going on. Fibromyalgia is not one disease. It is a label for what it looks like when four or five fixable problems stack up in the same body: hungry, damaged small nerves; a nervous system stuck with the volume turned all the way up; power plants in the cells that cannot keep the lights on; jumpy immune cells spraying chemicals on everything; and sleep that never gets deep enough to repair any of it. Pull those apart one at a time and most people get a lot better. Not overnight. But better.
I'll give you the short version first.
If the model is right: the levers, up front
- Get the sleep fixed before anything else. Nothing repairs while you are awake.
- Walk in warm water, or walk on land, starting absurdly low. Five minutes. Then six.
- Protein at every meal, salt your food, cut sugar and seed oils, and try four weeks low-histamine if you flush or react to foods.
- Supplements, in order: magnesium, vitamin D, the mitochondrial stack (CoQ10, acetyl-L-carnitine, alpha lipoic acid), B12 and thiamine, then PEA and apigenin for the pain and the mast cells. Brands and doses at the bottom.
- Pace with data (HRV), not with how brave you feel that morning.
- Get ferritin, vitamin D, B12 (the real test, MMA), magnesium, thyroid with free T3, and a morning cortisol checked. "Normal" panels miss this picture every time.
- If you are bendy, read the fibromyalgia as hypermobility with pain, because that is usually what it is.
Now let me show you why.
What the pain actually is
Pain is not made in your muscles. It is made in your brain, from signals that come in through nerves. In fibromyalgia two things have gone wrong with that system at once.
The wires are frayed. About half of people with fibromyalgia, when you biopsy a tiny piece of skin, have fewer of the smallest nerve fibers than they should. These are the same small fibers I wrote about in my POTS post here: they carry pain and temperature, and they run your autopilot (heart rate, blood vessels, gut, sweat). When they are damaged they do not go quiet. They misfire. They send pain signals for things that are not painful, like a shirt on your skin or a hand on your shoulder. That is why your pain moves around and why "nothing is wrong" on an X-ray. The problem is in wires too thin to image.
The volume knob is stuck on high. When pain signals come in for months, the spinal cord and brain change. They start turning up every signal, and they lose the ability to turn pain down. Doctors call this central sensitization. It is real and measurable, and it explains why fibromyalgia pain spreads, why light and noise and smells hurt, and why you feel everything more. But I want to be clear about something: the volume knob did not get stuck for no reason. It got stuck because the signals coming in were wrong for a long time. Fix the wires and the knob can come back down.
Why the wires fray: five things stacking up
I rarely find just one of these. I usually find three or four.
One: the nerves are starving. Small nerves need a steady supply of B12, thiamine (B1), B6, folate, magnesium, iron, copper, omega-3 fats, and vitamin D to repair themselves, and they wear out fast. Most of the fibromyalgia cases I have worked through are low-normal in several of these. Not deficient on the lab's scale, just low enough that repair never keeps up with damage. Low ferritin alone is enough to cause restless legs, poor sleep, fatigue, and widespread aching, and it is the single most common thing I find.
Two: the power plants are failing. Your muscles and nerves run on energy made in mitochondria. In fibromyalgia the mitochondria are measurably sluggish: they make less energy and throw off more sparks (oxidative stress). That is the bone-deep fatigue, the exercise that puts you in bed for two days, and part of the muscle pain, because a muscle that cannot make enough energy cannot relax either. I have a whole post on mitochondrial support here.
Three: the mast cells are jumpy. Mast cells are immune cells that live in your skin, your gut, and right next to your nerves. In a lot of the fibromyalgia cases I have worked through they fire constantly, releasing histamine and other chemicals that irritate the small nerves directly. If you flush, get hives, react to foods or wine, have a runny nose for no reason, or feel wired after eating, this is part of your story, and the usual fibromyalgia plan does nothing for it.
Four: the gut is leaking and feeding the fire. Almost everyone I see with fibromyalgia has irritable bowel symptoms, and most have bacterial overgrowth in the small intestine when we test for it. An irritated gut keeps the immune system on alert, blocks absorption of the exact nutrients the nerves need, and sends inflammatory signals straight to the brain. Low stomach acid is usually the first domino; my post on that is here.
Five: sleep is broken, so repair never happens. People with fibromyalgia do not get normal deep sleep. Brain wave recordings show awake-type activity intruding into the deepest stage, over and over, all night. Deep sleep is when nerves repair, when growth hormone is released, and when the brain rinses out inflammatory waste. Lose it and everything above gets worse the next day, which breaks sleep further. This loop is why I fix sleep first.
Two things make the whole picture worse. Stress hormones flatten out. After years of this, cortisol stops rising in the morning the way it should, so you wake up unrefreshed and in pain. And the thyroid turns the thermostat down. Your TSH is "normal," but the active hormone (free T3) runs low because a stressed body stops converting it. Cold, tired, heavy, foggy.
The bendy connection
A huge fraction of the fibromyalgia cases I have worked through are hypermobile: double-jointed, stretchy skin, easy bruising, joints that slip. Loose connective tissue means joints and muscles are constantly working overtime to hold you together, which is a lifetime of low-grade injury. It also comes bundled with POTS, mast cell problems, and gut problems. If this is you, the word fibromyalgia is describing the pain of a connective tissue disorder, and the plan has to include building strength and stability. More on that below.
What the model predicts would help, and why
1. Diet: feed the nerves, calm the mast cells, settle the gut
Protein at every meal, 25 to 35 grams. Nerves, muscles, and the sleep hormones are all built from it. Eggs, meat, fish, Greek yogurt, cottage cheese, lentils.
The nerve-repair foods, every week: eggs (choline, B12), beef or lamb (B12, iron, zinc, creatine), sardines or wild salmon (omega-3), liver once a week or desiccated liver capsules (the richest source of B12, folate, and copper there is), pumpkin seeds and dark greens (magnesium), sunflower seeds (thiamine, vitamin E), a cup of broccoli or cabbage a day. I am wary of canned tuna and big fish for these people I have worked with; mercury is hard on nerves. Small fish, or fresh wild salmon and trout.
Cut the three things that turn the volume up: sugar and refined flour (they spike insulin, which inflames nerves), industrial seed oils (soybean, corn, canola, "vegetable oil," which tilt your fats toward inflammation), and MSG and aspartame (both act on the same receptor the pain volume knob uses). Most of the people I have worked with notice the MSG one within two weeks.
Four-week low-histamine trial if your mast cells are jumpy: no leftovers older than a day, aged cheese, cured meat, wine and beer, vinegar, fermented foods, tomatoes, spinach, eggplant. Cook fresh and freeze the extra the same day. If you feel better, you have learned something important about your pain.
If your gut is the problem, a short low-FODMAP trial (four to six weeks, not forever) often drops bloating and pain together, and it tells you whether overgrowth is worth testing for.
Salt your food and drink 2 to 3 liters of water. A lot of fibromyalgia fatigue and dizziness is POTS wearing a different name.
2. Supplements, in the order the model suggests
The working rule is supplements as low as possible and food first. Add one at a time, a week apart, so you know what is doing what.
- Magnesium, 300 to 400 mg at night. Malate during the day is the fibromyalgia-specific form (it also feeds the energy cycle); glycinate at night for sleep. Seeking Health Magnesium Malate powder is my pick. Most people feel this one within a week in their muscles and their sleep.
- Vitamin D3 with K2, enough to get your blood level to 50 to 70. For most people that is 2,000 to 5,000 IU a day. Low D causes muscle pain on its own, and it is low in almost everyone with this diagnosis. Get tested.
- The mitochondrial stack. CoQ10 as ubiquinol, 200 mg with a meal (the best-studied supplement for fibromyalgia fatigue and pain, with several real trials behind it). Then acetyl-L-carnitine, 1,000 mg in the morning, which helps the power plants burn fat and has its own trials for fibromyalgia pain. Then alpha lipoic acid, 300 to 600 mg, which rebuilds your rust-proofing and repairs small nerves. Skip the alpha lipoic acid if you are pregnant, planning to be, or breastfeeding.
- B12 and thiamine. B12 1,000 mcg under the tongue as hydroxocobalamin plus adenosylcobalamin (no methyl group, so it will not wire you up). Benfotiamine 150 to 300 mg, a fat-soluble form of B1; a surprising number of fibromyalgia people I have worked with respond to high-dose thiamine, and it is cheap and safe to try. If you have ever gotten anxious or sleepless on methylfolate or methyl-B12, read my methyl trapping post here before touching any B complex, and use a plain one with folinic acid.
- Omega-3 fish oil, 2 grams of EPA plus DHA, always with a meal that has fat in it. Carlson Labs makes a good one.
- PEA (palmitoylethanolamide), 400 mg two or three times a day. This is a fat your own body makes to calm mast cells and overexcited nerves, and it has more trials for chronic pain than any other supplement in this model. It takes four to six weeks. Give it that long.
- Apigenin, 50 mg at bedtime. From chamomile and parsley; it calms mast cells and helps you fall asleep, which is why it is dosed at night in this model. If flushing and nerve pain are a big part of your picture, add vitamin E as mixed tocotrienols (Procapsin) a few weeks later.
- Creatine, 5 grams a day. It feeds muscle and brain energy directly and spares your methylation budget. Cheap and well studied.
- Iron, only if your ferritin is under 50, as bisglycinate every other day with vitamin C. Do not guess with iron; get the number.
- Melatonin, 1 to 3 mg, or glycine 3 grams, at bedtime if sleep onset is the problem. Both have small trials in fibromyalgia.
3. Lifestyle, which does most of the work in this model
- Sleep is the lever. Same bedtime every night, dark cool room, no screens for the last hour, no caffeine after noon, no alcohol (it wrecks deep sleep specifically). If you snore or wake gasping, get a sleep study; sleep apnea is found in a large fraction of fibromyalgia patients and treating it changes everything.
- Move, starting lower than feels reasonable. Exercise is the best-proven approach for fibromyalgia, and it fails when people start where they think they should be. Warm-water walking or swimming is the gentlest start: the water holds you up and the heat relaxes the muscles. Five minutes, three times a week. Add one minute a week. Add light strength work (bands, bodyweight) in month two. If you are bendy, build strength and stability and do not overstretch; yoga classes that push range of motion make hypermobile people I have worked with worse.
- Pace with data, not willpower. Track morning heart rate variability with a wearable or the Visible app. A low HRV morning is a rest day. Crashing for two days after one good day is the single most common way people lose months.
- Heat helps here. Unlike POTS, fibromyalgia usually loves heat: warm baths with Epsom salts, a heating pad, sauna if you tolerate it. If heat makes you dizzy or flushed, you probably have the POTS and mast cell picture too, and the POTS post applies.
- Turn the volume knob down on purpose. Slow breathing (four seconds in, six out) for five minutes, two or three times a day, directly calms the pain-amplifying part of the nervous system. Cold water on the face when a flare is building. Humming. These sound silly and they are free and they work.
- Morning light. Ten minutes outside within an hour of waking resets cortisol and your sleep clock.
- Lower the chemical load. Fragrance-free products, filtered water, HEPA filter in the bedroom. Fragrance and mold are mast cell triggers and a lot of the people I have worked with' flares track their environment.
- Get the hidden things tested. Ferritin, 25-OH vitamin D, methylmalonic acid (the real B12 test), red-cell magnesium, free T3 and reverse T3 along with TSH, a morning cortisol, and a breath test for small intestinal bacterial overgrowth if you bloat. These are the labs that are "normal" on a standard panel and abnormal when you look.
Where the medications fit in this model
The usual prescribed drugs (duloxetine, pregabalin, amitriptyline, cyclobenzaprine) turn the volume knob down. They do not fix the wires. They are reasonable bridges while you do the work above, and nothing here is a reason to stop them; that decision belongs to the person and their prescriber. The one I think is underused is low-dose naltrexone: a tiny dose at bedtime that calms the immune cells in the brain and spinal cord that keep the volume stuck, with real trials in fibromyalgia and very few side effects. Worth raising with a prescriber as a question. Opioids make fibromyalgia worse over time and the research literature does not support them in this picture.
The sequence the model predicts
Magnesium, sleep changes, and cutting MSG and sugar usually show up in two to three weeks. The mitochondrial stack and vitamin D take four to eight weeks for energy. The small nerves regrow over three to nine months, and that is when the pain itself changes, not just how well you cope with it. Progress is lumpy. Track it monthly, not daily, and expect flares along the way that mean nothing about the direction you are headed.
Educational content written from a research perspective, not medical advice. I am a PhD scientist, not a physician, and I do not diagnose, treat, cure, or prevent disease. What you have read is a model of what might be going on and what the published research suggests would address each piece if the model is right. Please take anything you want to try to your own healthcare provider, especially if you take prescription medication or have kidney, liver, or heart disease.
Framing
Fibromyalgia is defined by symptoms: widespread pain for at least three months with fatigue, unrefreshing sleep, and cognitive symptoms (2016 ACR criteria), in the absence of another explanation. The definition is a description of a phenotype and says nothing about mechanism. For most of the last thirty years the mechanism offered was central sensitization alone, which explained why nothing was found on imaging and justified a plan built on centrally acting drugs, graded exercise, and CBT.
The picture has changed. Since 2013, skin biopsy series have found reduced intraepidermal nerve fiber density in roughly 40 to 60 percent of fibromyalgia patients, meeting criteria for small fiber neuropathy. Corneal confocal microscopy finds the same. Passive transfer of IgG from fibromyalgia patients into mice reproduces mechanical and cold hypersensitivity, reduced IENFD, and reduced locomotor activity, with the antibodies binding satellite glia in the dorsal root ganglion. Muscle biopsies and phosphorus MR spectroscopy show impaired mitochondrial oxidative capacity. Polysomnography shows alpha intrusion into slow-wave sleep. None of this is "in the head."
My working model, from the cases I have worked through rather than from a single trial: fibromyalgia is the phenotype produced when a peripheral small fiber lesion (substrate failure, mast cell mediators, mitochondrial dysfunction, in some cases autoimmunity) drives sustained abnormal afferent input into a CNS that then sensitizes, with disrupted slow-wave sleep, HPA axis flattening, and thyroid downregulation locking the state in. Connective tissue laxity and gut dysbiosis are the commonest amplifiers. The central sensitization is real, but it is downstream, and it is plastic. Address the periphery and the sleep and the model predicts it reverses.
1. The peripheral lesion
Small fiber neuropathy
Unmyelinated C fibers and thinly myelinated A-delta fibers carry nociception, temperature, and autonomic outflow. They have the highest turnover and the least metabolic reserve of any neuron, maintained by axonal transport over up to a meter. Damaged small fibers do not simply fall silent: surviving fibers develop ectopic firing, sodium channel upregulation (Nav1.7, Nav1.8), and lowered thresholds, which is the peripheral source of allodynia, burning pain, and the migrating quality of fibromyalgia pain. The autonomic fibers are the same population, which is why orthostatic intolerance, gastroparesis, sudomotor dysfunction, and temperature dysregulation travel with the diagnosis.
The substrate dependencies are the ones I set out in the POTS post here: cobalamin, thiamine, pyridoxal-5-phosphate, riboflavin, folate, choline, DHA, copper, iron, magnesium, vitamin D, vitamin E. In fibromyalgia the three I find low most consistently are ferritin, 25-OH vitamin D, and functional B12 (elevated MMA with normal serum B12). Ferritin under 50 ng/mL independently predicts restless legs, fragmented sleep, fatigue, and reduced pain threshold, plausibly through tyrosine hydroxylase and dopamine synthesis in the spinal dorsal horn. Thiamine deficiency presents as fatigue and polyneuropathy before any classical sign; the open-label response to high-dose thiamine in fibromyalgia reported by Costantini is consistent with a functional, transport-limited deficiency rather than dietary lack.
Mast cell mediators
Mast cells sit perivascularly and in direct apposition to small fiber terminals, and skin biopsies in fibromyalgia show increased dermal mast cell numbers. Tryptase and chymase activate PAR-2 on C fibers, sensitizing TRPV1 and TRPA1; histamine at H1 and H4 drives itch and pain; PGD2 and NGF from mast cells lower nociceptor thresholds and drive sprouting. NGF is also the mediator with the strongest link to peripheral sensitization in human chronic pain models. As in the MCAS cases I have worked through, serum tryptase is rarely informative; plasma heparin, urinary PGD2 metabolite, and the clinical picture (flushing, dermatographism, food and alcohol reactivity) are what I rely on.
Mitochondrial dysfunction
Muscle biopsy, 31P-MRS, and blood mononuclear cell studies in fibromyalgia show reduced CoQ10, reduced mitochondrial membrane potential, reduced ATP, increased mitochondrial ROS, lipid peroxidation, and reduced mitochondrial mass with impaired mitophagy. Mitochondrial failure in the axon is itself a cause of small fiber degeneration, since axonal transport and membrane maintenance are ATP-limited, and in muscle it produces the inability to relax (calcium reuptake is ATP-dependent), post-exertional malaise, and lactate accumulation. CoQ10 repletion normalizes several of these markers and improves pain, fatigue, and headache in randomized trials; ALCAR has randomized data against duloxetine with comparable pain reduction and better tolerability.
Autoimmunity
The passive transfer studies (Goebel and colleagues, 2021 onward) are the most important new finding in the field: patient IgG is sufficient to produce the sensory phenotype and reduce IENFD in mice, and the antibodies target satellite glial cells in the DRG. This is not yet a clinical test, but it reframes a subset of fibromyalgia as an antibody-mediated small fiber ganglionopathy, which would predict response to IVIG (small open-label series are positive) and to immune modulation more broadly. I think of this subset as the people with abrupt post-infectious onset, and the model lowers the threshold for measuring the autoantibodies that are available (ganglionic AChR, TS-HDS, FGFR3).
2. The central lesion
Sustained abnormal afferent input produces central sensitization: NMDA receptor activation and phosphorylation in dorsal horn neurons, loss of descending noradrenergic and serotonergic inhibition, microglial and astrocyte activation with IL-1beta, TNF-alpha, and BDNF release, and expansion of receptive fields. Neuroimaging shows reduced connectivity of the periaqueductal gray (descending inhibition) and increased insula connectivity. Cerebrospinal fluid shows elevated substance P and glutamate and reduced GABA. PET studies show cortical microglial activation.
Three nutritional and metabolic inputs act directly on this machinery. Magnesium is the physiological NMDA channel blocker; deficiency lowers the sensitization threshold. Dietary glutamate (MSG, hydrolyzed protein, aspartame) raises the excitatory load; a controlled dietary challenge study reproduced symptoms on reintroduction. Tetrahydrobiopterin, the cofactor for tyrosine and tryptophan hydroxylase, is depleted by oxidative stress and inflammation, which limits the serotonin and norepinephrine available for descending inhibition; this is the mechanism the SNRIs are compensating for.
3. The locking mechanisms
Slow-wave sleep disruption. Alpha-delta sleep in fibromyalgia reduces stage N3 and the growth hormone pulse it carries. Experimentally interrupting N3 in healthy adults produces fibromyalgia-like myalgia and tenderness within days. Reduced N3 impairs glymphatic clearance of inflammatory mediators, lowers pain thresholds the next day, and suppresses the IGF-1 needed for muscle and nerve repair. Obstructive sleep apnea and upper airway resistance syndrome are found in a large fraction of fibromyalgia patients, especially the hypermobile ones, and are under-diagnosed because the patients are often young women who do not fit the stereotype.
HPA axis. Years of sustained nociceptive and inflammatory signaling flatten the cortisol awakening response and blunt the diurnal slope; low morning cortisol correlates with pain and fatigue in cohort data. This is not adrenal failure; it is central downregulation of a chronically driven axis.
Thyroid downregulation. IL-6, cortisol, and caloric or psychological stress reduce deiodinase 1 activity (selenium-dependent) and raise reverse T3, so free T3 runs low with a normal TSH. The clinical result is cold intolerance, fatigue, weight gain, and myalgia that overlaps the primary picture.
Gut. SIBO is detected by breath test in the majority of fibromyalgia patients in several series, and eradication reduces pain scores. Dysbiosis raises LPS and histamine load, impairs absorption of iron, B12, magnesium, and thiamine, and sustains mast cell priming. Reduced butyrate producers are a consistent microbiome finding. Low gastric acid is usually the proximal lesion here.
Amplifiers
Connective tissue laxity. Hypermobility is present in a large fraction of fibromyalgia cohorts, and the hEDS/HSD population has fibromyalgia-level pain as a near-universal feature. The mechanisms are mechanical (joint instability, microtrauma, proprioceptive loss, chronic muscle guarding), autonomic (venous pooling and small fiber neuropathy), and immune (mast cell activation is over-represented). In these people I have worked with fibromyalgia is the pain phenotype of the connective tissue disorder, and the lever emphasis shifts toward stability, proprioception, and the POTS and mast cell model.
Xenobiotic load and oxidative stress. The same cumulative-load model I work from for metabolic disease applies: phase II detoxification and glutathione regeneration compete for the same cysteine, glycine, NADPH, and selenium that the nervous system needs, and GGT runs high in a subset of the fibromyalgia cases I have worked through with no alcohol history.
Post-infectious onset. Fibromyalgia follows EBV, Lyme, SARS-CoV-2, and other infections at a recognizable rate. I read this as the trigger that pushed a body already carrying two or three of the above into the full phenotype.
Markers that would test the model
Beyond the clinical criteria:
- Ferritin and transferrin saturation; hs-CRP (ferritin is an acute phase reactant and reads falsely high in inflammation)
- 25-OH vitamin D; RBC magnesium; methylmalonic acid and homocysteine; plasma thiamine or erythrocyte transketolase; copper and ceruloplasmin; zinc; omega-3 index
- TSH, free T4, free T3, reverse T3, TPO antibodies, selenium
- Morning salivary or serum cortisol, ideally a four-point diurnal curve; DHEA-S
- Mast cell: plasma heparin, urinary 11-beta-PGF2-alpha and N-methylhistamine (24 hour, refrigerated), chromogranin A; tryptase interpreted cautiously
- Lactulose or glucose breath test for SIBO; comprehensive stool analysis with calprotectin, zonulin, and SCFAs
- Polysomnography when there is snoring, witnessed apnea, or morning headache, and in every hypermobile person with unrefreshing sleep
- Skin biopsy for IENFD when the diagnosis is contested or the person needs the finding to access care; corneal confocal microscopy where available
- Autoantibodies when onset was post-infectious or the autonomic picture is prominent: ganglionic AChR, TS-HDS, FGFR3, adrenergic and muscarinic receptor antibodies
- Oxidative stress and detox capacity: GGT, RBC glutathione, 8-OHdG, organic acids with mitochondrial intermediates
- Beighton score and a connective tissue history in every person
- Genotype where it will change management: MTHFR, MTR, MTRR, COMT V158M, HNMT, AOC1, GCH1 (BH4 synthesis, a known pain-sensitivity gene), SCN9A, TNXB, COL5A1
What the model predicts: addressing each node
The therapeutic sequence is: restore slow-wave sleep, replete substrate and mitochondrial cofactors, reduce mast cell and gut-derived mediator load, retrain the periphery with graded movement, and let central sensitization unwind. Expect three to nine months for the peripheral repair and for pain intensity (not only coping) to change.
Diet
- Protein 1.2 to 1.6 g/kg, 25 to 35 g per meal, for axonal repair, muscle, and the glycine, cysteine, and tryptophan supply.
- Neurotrophic food targets, as in the POTS model: eggs, red meat, small oily fish (sardine, herring, anchovy, fresh wild salmon and trout; not tuna or swordfish), liver 2 to 3 oz weekly or desiccated liver capsules, pumpkin and sunflower seeds, dark greens, cruciferous vegetables daily.
- Remove excitotoxic and pro-inflammatory inputs: monosodium glutamate, hydrolyzed and autolyzed proteins, aspartame; refined sugar and flour; industrial seed oils. The MSG and aspartame exclusion has a controlled challenge study behind it and is the single dietary change the people I have worked with notice fastest.
- Histamine restriction trial, four weeks, when mast cell signs are present: aged, fermented, cured, and leftover foods, alcohol, vinegar, tomato, spinach, eggplant. Cook fresh and freeze same day. Reintroduce systematically.
- Low-FODMAP trial, four to six weeks, when IBS symptoms dominate, as a step toward SIBO testing, not as a permanent diet. Treated SIBO (rifaximin, or herbal regimens such as berberine, oregano, and neem, with a biofilm agent) reduces pain scores in the published series.
- Sodium 6 to 10 g NaCl and 2 to 3 L fluid when orthostatic symptoms are present.
- Alcohol out during the repair phase: it fragments N3 sleep, lowers pain thresholds, and consumes glutathione.
Supplements, in the order the model suggests
One agent per week, titrated.
- Magnesium malate 300 to 400 mg elemental, divided; glycinate at night. Malate supplies a TCA intermediate and has randomized data in fibromyalgia; magnesium is the physiological NMDA antagonist and a mast cell stabilizer. Seeking Health Magnesium Malate powder.
- Vitamin D3 to a 25-OH-D of 50 to 70 ng/mL with K2 (MK-7 100 to 200 mcg). Repletion reduces pain scores in randomized trials in deficient fibromyalgia patients.
- Mitochondrial stack: ubiquinol 200 to 300 mg with a meal (randomized trials show reduced pain, fatigue, and inflammatory markers and restored mitochondrial markers); acetyl-L-carnitine 1,000 to 1,500 mg in the morning (randomized data comparable to duloxetine for pain); R-alpha-lipoic acid 300 to 600 mg (glutathione and tocopherol regeneration, best-evidenced nutraceutical in small fiber neuropathy). ALA withheld in pregnancy, planned pregnancy, and breastfeeding.
- Cobalamin and thiamine: hydroxocobalamin plus adenosylcobalamin 1,000 to 2,000 mcg sublingual; benfotiamine 150 to 300 mg or TTFD 100 mg, titrating thiamine upward (Costantini used 600 to 1,800 mg thiamine HCl) when the fatigue phenotype dominates and the response to the first 300 mg is encouraging. Non-methylated B complex with folinic acid, riboflavin-5-phosphate, and P5P at quarter-dose titration; methyl donors only after demonstrated tolerance, per the methyl trapping post here. Creatine 5 g and phosphatidylcholine 1,200 to 2,400 mg as methyl-sparing support before any methylated agent.
- Omega-3 2 to 3 g EPA plus DHA with a fat-containing meal; resolvin precursors for the resolution of neuroinflammation.
- Palmitoylethanolamide 400 mg two to three times daily (micronized or ultramicronized). PEA is an endogenous PPAR-alpha agonist that down-regulates mast cell and microglial activation and has the largest clinical trial base of any nutraceutical in chronic neuropathic and fibromyalgia pain; onset is four to six weeks.
- Apigenin 50 mg at bedtime as the mast cell stabilizer (degranulation and IL-6 inhibition, CD38 inhibition sparing NAD+, mild GABA-A activity supporting sleep onset); luteolin 100 mg by day where mast cell signs are prominent. Mixed tocotrienols 100 to 200 mg after several weeks for membrane-phase protection of the regenerating axon.
- Iron bisglycinate 25 to 50 mg every other day with vitamin C when ferritin is below 50 (the literature supports 75 as the threshold when restless legs are present), rechecking at 12 weeks.
- Sleep: melatonin 1 to 3 mg (randomized data in fibromyalgia for pain and sleep), glycine 3 g at bedtime (improves subjective sleep quality and supplies a conjugation substrate), and magnesium glycinate. 5-HTP 50 to 100 mg at night has older randomized data and is reasonable when serotonergic drugs are not on board; it is not combined with SSRIs or SNRIs.
- Selenium 100 to 200 mcg when free T3 is low with normal T4; NAC 600 to 1,200 mg or liposomal glutathione when GGT or oxidative markers are elevated; D-ribose 5 g three times daily for two to three weeks as a trial when post-exertional malaise is severe (open-label data only, but low risk).
- Low-dose naltrexone, 1.5 to 4.5 mg at bedtime, by prescription. LDN antagonizes TLR4 on microglia and reduces central glial activation; randomized crossover trials in fibromyalgia show meaningful pain reduction with a benign side-effect profile. I think it is the most under-used agent in this condition and it is a question worth taking to a prescriber.
Lifestyle
The largest effect sizes in the fibromyalgia literature belong to exercise and sleep, and they only work in this sequence.
- Sleep first. Fixed schedule, 8 to 9 hours, dark and cool, no screens in the last hour, caffeine cut-off at noon, no alcohol. Formal CBT-I when insomnia is entrenched. Polysomnography and approach of apnea or UARS before anything else is judged to have failed.
- Graded exercise from below threshold. Aquatic exercise in warm water (32 to 34 C) has the best tolerability data for de-conditioned patients: 5 to 10 minutes, three times weekly, with weekly increments of one to two minutes. Land walking and recumbent cycling follow. Resistance training begins in month two with bands and bodyweight and has randomized data for pain, strength, and depression in fibromyalgia. For hypermobile people the model emphasizes closed-chain stability and proprioception and avoids end-range stretching and flexibility-focused yoga. Progress is gated by symptoms, never by schedule.
- Objective pacing. Morning HRV (RMSSD) via wearable or the Visible app; a reading more than one standard deviation below baseline is a rest day. Post-exertional malaise is a sequence error, not a target.
- Heat. Unlike POTS, fibromyalgia pain generally responds to heat: warm baths with magnesium sulfate, local heat, and sauna where tolerated (sauna has small positive trials). Heat intolerance, flushing, or orthostatic worsening with heat indicates the POTS and mast cell overlap, and the POTS model's thermal rules apply instead.
- Descending inhibition training. Slow breathing at 5 to 6 breaths per minute, 5 minutes two to three times daily, raises vagal tone and baroreflex sensitivity; the baroreflex is itself antinociceptive. Cold-water face immersion and humming for acute flares. Mindfulness-based and acceptance-based programs have moderate randomized evidence and I frame them as volume-knob training, not as a statement about where the pain comes from.
- Circadian anchoring. Morning outdoor light within an hour of waking; dim light and no food after dark; consistent meal timing.
- Environmental load. Fragrance-free products, filtered water, HEPA filtration in the bedroom, mold assessment with any water-damage history.
- Adjunct therapies with evidence: acupuncture (moderate evidence for pain), tai chi (randomized data comparable to aerobic exercise with better adherence), massage, transcranial direct current stimulation and repetitive TMS over motor cortex (modest effects, specialist settings), hyperbaric oxygen (small trials with imaging changes), and photobiomodulation (early data).
- Where prescribed medications fit. Duloxetine, milnacipran, pregabalin, amitriptyline, and cyclobenzaprine are bridges that act on the central lesion and do not conflict with this sequence; doses often come down over 6 to 12 months. Opioids are avoided: they worsen central sensitization through opioid-induced hyperalgesia and microglial TLR4 activation, and the evidence base in fibromyalgia is negative.
Markers to follow, and the sequence the model predicts
Pain, fatigue, and sleep scores monthly (FIQR or a simple 0 to 10 for each). Ferritin, MMA, vitamin D, and thyroid at 12 weeks; mast cell markers and omega-3 index at 6 months. The expected sequence: sleep and muscle tightness respond to magnesium, MSG exclusion, and sleep structure within two to four weeks; energy responds to the mitochondrial stack and vitamin D over four to eight weeks; PEA and LDN change pain intensity over six to twelve weeks; and peripheral regeneration, visible as a change in the character of the pain and a widening of the activity window, tracks the exercise program from month three to month nine. Clients with hypermobility and the mast cell and POTS overlap progress more slowly and need all three protocols run together.
Educational and research content, not medical advice. The author holds a PhD in cellular and molecular nutrition, is not a licensed physician, and does not diagnose, treat, cure, or prevent disease. The sequences described are what this model predicts would address each node if the model is correct, with the supporting literature cited in the text; they are offered for discussion with a qualified clinician, who should manage any agent with contraindications or interactions.
